Wednesday February 18, 2015 0 comments
AURORA - Ginny Orndorff has been named new executive director for the Colorado Institute for Drug, Device and Diagnostic Discovery (CID4) following the retirement of former director Kevin Smith.
CID4 is a nonprofit commercial innovation accelerator supported by the Colorado Office of Economic Development and International Trade (OEDIT).
Orndorff's selection was made after a national search and selection process conducted by an ad hoc committee of CID4 board members.
"We are very pleased to announce this appointment," said Jonathan Thorne, acting CID4 board chair. "Ginny will bring leadership and ingenuity to the CID4 programs, along with a deep sense of commitment to Colorado's bioscience community. She is a serial entrepreneur with experience in all aspect of bioscience startups."
Orndorff brings more than 30 years of bioscience company management to her CID4 role. She was founder and CEO of GenoPlex in Denver and also served as director of technology/business development for NeXstar n Boulder and as director of biotechnology programs at the Colorado Advanced Technology Institute.
"CID4 has played an important role in helping high-potential entrepreneurial bioscience companies through early-stage challenges, strengthening their foundation and positioning them to grow and thrive," Orndorff said.
"Colorado's research institutions garner over $600 million in federal funds for top-notch bioscience research. This provides a rich resource for entrepreneurs throughout the state to develop groundbreaking products to fill important medical needs and enhance Colorado's economy.
"I look forward to continuing to build CID4's capabilities and impact."